Latest News of VECT
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug
By Yahoo! Finance |
1 week ago
Nuvectis Pharma, Inc. stock declined due to Phase 1b study results on NXP800 for ovarian cancer. Efficacy was observed with some patients showing tumor responses. The company plans to increase dosage ...
Vection Technologies Full Year 2024 Earnings: AU$0.009 loss per share (vs AU$0.01 loss in FY 2023)
By Yahoo! Finance |
1 month ago
Vection Technologies' shares have increased by 13% in the past week. Before making decisions, be aware of the 4 warning signs identified for the company. Simply Wall St's article offers general analys...
Vector Group Ltd. (VGR) Stock Price, News, Quote & History
By Yahoo! Finance |
3 months ago
Vector Group Ltd. manufactures and sells cigarettes in the US, operating in Tobacco and Real Estate segments. It produces various cigarette brands and invests in real estate properties. Founded in 187...
-
VGR Stock Price | Vector Group Ltd. Stock Quote (U.S.: NYSE) | MarketWatch
By MarketWatch | 3 months agoVector Group Ltd. is a holding company involved in distributing tobacco products, real estate investments, and other operations. Established in 1980, it is based in Miami, FL....
-
Vector Group Shows Rising Price Performance With Jump To 89 RS Rating
By Investor's Business Daily | 3 months agoInstitutional support plays a crucial role in stock performance. IBD's RS Rating gauges technical strength by comparing a stock's price performance over 52 weeks against its peers. Stocks with RS Rati...
-
Insiders hold 65% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently
By Yahoo! Finance | 3 months agoNuvectis Pharma's significant insider control indicates vested interests in company growth. Insiders owning 65% of shares show commitment and potential stock price rise. Institutional investors also h...
-
Agilent to Acquire Canadian CDMO BIOVECTRA for $925 Million
By Yahoo! Finance | 3 months agoAgilent Technologies is acquiring Canadian CDMO BIOVECTRA for $925 million to strengthen its biopharma solutions, expand services, and enhance expertise in areas like ADCs and HPAPIs....
-
Agilent to buy contract drug manufacturer Biovectra for $925 million
By Yahoo! Finance | 4 months agoAgilent Technologies is acquiring Biovectra for $925 million to enhance its services for biotech companies. Biovectra provides services for drug manufacturers and specializes in active ingredients for...
-
In the wake of Vector Group Ltd.'s (NYSE:VGR) latest US$72m market cap drop, institutional owners may be forced to take severe actions
By Yahoo! Finance | 4 months agoIn Vector Group Ltd., institutional investors hold a 60% ownership stake, facing significant upside or downside potential. Despite recent losses, they play a key role in influencing stock price moveme...